Protocol Page


	Study ID (Protocol Number)
	AI444-046


	STUDY LOCATIONS*
	Alabama Liver & Digestive Specialists (Alds) Montgomery, AL 36116 Recruiting	Carolinas Center For Liver Disease Statesville, NC 28677 Recruiting
	Alamo Medical Research San Antonio, TX 78215 Recruiting	Dean Clinic Madison, WI 53715 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial
	STUDY OVERVIEW
	The primary purpose of this study is to determine whether the hepatitis C virus continues to remain unable to be detected in subjects who were previously treated with Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) and achieved sustained virologic response.

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.